ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,255.52
0.47%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. ADC Therapeutics SA (ADCT)

  7. ADC Therapeutics SA (ADCT) News

ADC Therapeutics (ADCT)

ADC Therapeutics SA
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:ADCT
DateTimeSourceHeadlineSymbolCompany
15/05/202412:15GlobeNewswire Inc.ADC Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNYSE:ADCTADC Therapeutics SA
14/05/202417:32Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
09/05/202421:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ADCTADC Therapeutics SA
09/05/202412:15GlobeNewswire Inc.ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare ConferenceNYSE:ADCTADC Therapeutics SA
08/05/202421:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
07/05/202421:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ADCTADC Therapeutics SA
07/05/202421:02Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
06/05/202412:30GlobeNewswire Inc.ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded WarrantsNYSE:ADCTADC Therapeutics SA
06/05/202411:51Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:ADCTADC Therapeutics SA
06/05/202411:38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ADCTADC Therapeutics SA
06/05/202411:29Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
06/05/202411:10GlobeNewswire Inc.ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
06/05/202411:00GlobeNewswire Inc.ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone LymphomaNYSE:ADCTADC Therapeutics SA
01/05/202421:05GlobeNewswire Inc.ADC Therapeutics Makes Grants to New Employees Under Inducement PlanNYSE:ADCTADC Therapeutics SA
01/05/202412:00GlobeNewswire Inc.ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024NYSE:ADCTADC Therapeutics SA
04/04/202412:00GlobeNewswire Inc.ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin LymphomaNYSE:ADCTADC Therapeutics SA
03/04/202412:00GlobeNewswire Inc.ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024NYSE:ADCTADC Therapeutics SA
01/04/202421:05GlobeNewswire Inc.ADC Therapeutics Makes Grants to New Employees Under Inducement PlanNYSE:ADCTADC Therapeutics SA
13/03/202411:03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNYSE:ADCTADC Therapeutics SA
13/03/202411:00GlobeNewswire Inc.ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdatesNYSE:ADCTADC Therapeutics SA
06/03/202412:15GlobeNewswire Inc.ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes SummitNYSE:ADCTADC Therapeutics SA
06/03/202412:00GlobeNewswire Inc.ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024NYSE:ADCTADC Therapeutics SA
05/03/202422:45GlobeNewswire Inc.ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual MeetingNYSE:ADCTADC Therapeutics SA
05/03/202414:15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
29/02/202421:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
27/02/202412:00GlobeNewswire Inc.ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care ConferenceNYSE:ADCTADC Therapeutics SA
24/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
19/01/202421:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
04/01/202412:15Edgar (US Regulatory)Form 8-K - Current reportNYSE:ADCTADC Therapeutics SA
04/01/202412:15GlobeNewswire Inc.ADC Therapeutics Regains Compliance with NYSE Continued Listing StandardsNYSE:ADCTADC Therapeutics SA
 Showing the most relevant articles for your search:NYSE:ADCT

Your Recent History

NASDAQ
TRMB
Trimble
COIN
YINUSD
YIN Finance
NASDAQ
JGGCW
Jaguar Global Growth Cor...
LSE
PPB
Paddy Power Betfair
USOTC
SYQH
Liaoning Shuiyun Qinghe ... (CE)
LSE
KIBO
Kibo Energy
BOV
N1VO34
Novo Nordisk
BOV
ITUBH318
ITUBH318 Ex:30,41
NYSE
TRB
Tribune
NYSE
KMPR
Kemper
BMF
DCOF32
DCOF32 - Janeiro 2032
NASDAQ
CFVI
CF Acquisition Corporati...
LSE
0M32
Stora Enso Oyj
NASDAQ
GPRAFX
Putnam Retirement Advant...
ASX
THG
Thakral Holdings
BIT
F08503
Vontobel Financial Produ...
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved